Updated time: 2024-03-19 11:55:07
30A-1030312
TW I681052、US 10865397 B2、JP 6964622、CA 3109156、US 11,781,124 B2、CL 67.759 、EP 3460044
The present disclosure relates to biosynthesis of astaxanthin or its precursors or derivatives. We designed a host for metabolite biosynthesis via integration of multiple genes from different organisms and utilizing suitable gene promoters. The case study demonstrated our design of a cell factory for astaxanthin production. Due to the antioxidant efficacy of the astaxanthin and/or its precursors or derivatives, the present invention also provides a method for improving the tolerance of a host cell to toxins and a method for enhancing the productivity of a host in producing ethanol or baccatin III.
Technological Advantages
- Many carotenoids are cheaply produced by chemical synthesis, but it causes high environmental pollution, and its product is not well accepted by food and pharmaceutical markets. On the other hand, current technologies have many limitations for carotenoids bioproduction and cannot economically compete with chemical synthesis. In contrast, our cell factory has a potential for economical bioproduction of carotenoids.
- The present design can integrate multiple astaxanthin biosynthesis genes from different organisms via the PGASO technique and adjust gene expression ratios using suitable promoters. This cell factory has a potential for economical astaxanthin bioproduction.
- Synthetic astaxanthin is a mixture of the (3S, 3’S), (3R, 3’S), and (3R, 3’R) isomers, in which the 3R, 3’S has no antioxidant activity. In contrast, our astaxanthin biosynthesis method produces mainly the most desirable 3S, 3S-isomer.
- Due to the antioxidant efficacy of the astaxanthin and/or its precursor or derivative, the present invention also provides a method for improving the tolerance of a host cell to toxins and a method for enhancing a host to produce ethanol or baccatin III.
Applications of Technology
This invention includes the application of the PGASO technique and the biosynthesis of astaxanthin.
- PGASO can be applied to construct a desired metabolic pathway in a host to generate a specific product. It can increase the efficiency of in vitro or in vivo enzyme reactions for producing the biological products or therapeutic biological product for biopharmaceutical applications.
- This technique employs overlapping oligonucleotides for recombinatorial assembly of gene cassettes with individual promoters to produce natural product, biofuel, or food additives.
- Carotenoids, which are light harvesting pigments and synthesized by many photosynthetic organisms, can protect the photosynthetic apparatus from photo-oxidative damage under excessive light. In humans, carotenoids, which are the precursor of vitamin A and may function as antioxidants, can stimulate the immune system and can provide protection against a broad range of human diseases, including cancer.
- Astaxanthin (3, 3'-dihydroxy-ß-carotene-4, 4'-dione) is one of the best-selling products in the carotenoid market. Its commercial use is mainly as a feed additive for salmon and trout farming. It is a carotenoid pigment, which confers a characteristic coloration to some birds, crustaceans and salmon.
- As the red carotenoid astaxanthin possesses higher antioxidant activity than other carotenoids, it has a great commercial potential for use in aquaculture, pharmaceutical, cosmetics, and food industries. It is thought that an upset in the oxidative balance can contribute to rheumatoid arthritis, heart disease, Parkinson’s disease, Alzheimer’s disease, cancer, and stroke.
- Carotenoids also can help improve the tolerance of a host cell to a toxin and enhance the productivity of a host in producing ethanol or high economic products.
Jui-Jen CHANG, Caroline THIA, Chieh-Chen HUANG, Wen-Hsiung LI, Hao-Yeh LIN, Yu-Ju LIN
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

A method for designing the biosynthesis pathway of carotenoids and their derivatives in a cell